{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T13:01:02Z","timestamp":1788786062398,"version":"build-2803163510"},"reference-count":59,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100020828","name":"Royan Institute for Stem Cell Biology and Technology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100020828","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transplantation and Cellular Therapy"],"published-print":{"date-parts":[[2024,7]]},"DOI":"10.1016\/j.jtct.2024.04.013","type":"journal-article","created":{"date-parts":[[2024,4,24]],"date-time":"2024-04-24T01:56:12Z","timestamp":1713923772000},"page":"694.e1-694.e10","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["The Application of Umbilical Cord Blood-derived Platelet Gel for Skin Ulcers Associated With Chronic Graft-Versus-Host Disease in Pediatrics: A Randomized Trial"],"prefix":"10.1016","volume":"30","author":[{"given":"Rashin","family":"Mohseni","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5250-1542","authenticated-orcid":false,"given":"Pouya","family":"Mahdavi Sharif","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5213-106X","authenticated-orcid":false,"given":"Abbas","family":"Khosravi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmad Reza","family":"Taheri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maryam","family":"Behfar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Morteza","family":"Zarrabi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leila","family":"Jafari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fahimeh","family":"Jafari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zeynab","family":"Nikfetrat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Parisa","family":"Naji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amir Ali","family":"Hamidieh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.jtct.2024.04.013_bib0001","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1038\/bmt.2014.299","article-title":"Hematopoietic SCT in Iranian children 1991-2012","volume":"50","author":"Hamidieh","year":"2015","journal-title":"Bone Marrow Transplant"},{"issue":"1","key":"10.1016\/j.jtct.2024.04.013_bib0002","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1038\/s41572-018-0025-4","article-title":"Lysosomal storage diseases","volume":"4","author":"Platt","year":"2018","journal-title":"Nat Rev Dis Primers"},{"issue":"5","key":"10.1016\/j.jtct.2024.04.013_bib0003","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1038\/s41409-018-0333-z","article-title":"Challenges in managing graft-versus-host disease in developing countries: a perspective","volume":"54","author":"Saleem","year":"2019","journal-title":"Bone Marrow Transplant"},{"issue":"1","key":"10.1016\/j.jtct.2024.04.013_bib0004","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/s40257-017-0306-9","article-title":"Cutaneous graft-versus-host disease: diagnosis and treatment","volume":"19","author":"Strong Rodrigues","year":"2018","journal-title":"Am J Clin Dermatol"},{"issue":"1","key":"10.1016\/j.jtct.2024.04.013_bib0005","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1186\/s13287-023-03498-y","article-title":"Evaluation of safety and efficacy of allogeneic adipose tissue-derived mesenchymal stem cells in pediatric bronchiolitis obliterans syndrome (BoS) after allogeneic hematopoietic stem cell transplantation (allo-HSCT)","volume":"14","author":"Mohseni","year":"2023","journal-title":"Stem Cell Res Ther"},{"issue":"2","key":"10.1016\/j.jtct.2024.04.013_bib0006","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.bbmt.2014.10.021","article-title":"Increasing incidence of chronic graft-versus-host disease in allogeneic transplantation: a report from the Center for International Blood and Marrow Transplant Research","volume":"21","author":"Arai","year":"2015","journal-title":"Biol Blood Marrow Transplant"},{"issue":"17","key":"10.1016\/j.jtct.2024.04.013_bib0007","doi-asserted-by":"crossref","first-page":"4651","DOI":"10.1182\/blood-2010-11-319509","article-title":"Patient-reported quality of life is associated with severity of chronic graft-versus-host disease as measured by NIH criteria: report on baseline data from the chronic GVHD consortium","volume":"117","author":"Pidala","year":"2011","journal-title":"Blood"},{"issue":"11","key":"10.1016\/j.jtct.2024.04.013_bib0008","doi-asserted-by":"crossref","first-page":"1973","DOI":"10.1016\/j.bbmt.2015.07.025","article-title":"Long-term morbidity and mortality in children with chronic graft-versus-host disease classified by National Institutes of Health Consensus criteria after allogeneic hematopoietic stem cell transplantation","volume":"21","author":"Inagaki","year":"2015","journal-title":"Biol Blood Marrow Transplant"},{"issue":"1","key":"10.1016\/j.jtct.2024.04.013_bib0009","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jaad.2022.12.024","article-title":"Chronic graft-versus-host disease. Part I: epidemiology, pathogenesis, and clinical manifestations","volume":"90","author":"Baumrin","year":"2024","journal-title":"J Am Acad Dermatol"},{"issue":"25","key":"10.1016\/j.jtct.2024.04.013_bib0010","doi-asserted-by":"crossref","first-page":"5098","DOI":"10.1182\/blood-2012-10-464198","article-title":"Incidence, risk factors, and outcomes of sclerosis in patients with chronic graft-versus-host disease","volume":"121","author":"Inamoto","year":"2013","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.jtct.2024.04.013_bib0011","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1038\/s41409-019-0731-x","article-title":"Ruxolitinib in refractory acute and chronic graft-versus-host disease: a multicenter survey study","volume":"55","author":"Escamilla G\u00f3mez","year":"2020","journal-title":"Bone Marrow Transplant"},{"issue":"1","key":"10.1016\/j.jtct.2024.04.013_bib0012","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2020.34750","article-title":"Evaluation of ruxolitinib for steroid-refractory chronic graft-vs-host disease after allogeneic hematopoietic stem cell transplantation","volume":"4","author":"Wu","year":"2021","journal-title":"JAMA Netw Open"},{"issue":"2","key":"10.1016\/j.jtct.2024.04.013_bib0013","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1158\/1078-0432.CCR-15-1443","article-title":"A randomized phase II crossover study of imatinib or rituximab for cutaneous sclerosis after hematopoietic cell transplantation","volume":"22","author":"Arai","year":"2016","journal-title":"Clin Cancer Res"},{"issue":"1","key":"10.1016\/j.jtct.2024.04.013_bib0014","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1182\/blood-2016-02-702852","article-title":"Efficacy, durability, and response predictors of low-dose interleukin-2 therapy for chronic graft-versus-host disease","volume":"128","author":"Koreth","year":"2016","journal-title":"Blood"},{"issue":"21","key":"10.1016\/j.jtct.2024.04.013_bib0015","doi-asserted-by":"crossref","first-page":"2243","DOI":"10.1182\/blood-2017-07-793786","article-title":"Ibrutinib for chronic graft-versus-host disease after failure of prior therapy","volume":"130","author":"Miklos","year":"2017","journal-title":"Blood"},{"issue":"25","key":"10.1016\/j.jtct.2024.04.013_bib0016","doi-asserted-by":"crossref","first-page":"2836","DOI":"10.1182\/blood-2017-05-780239","article-title":"Phase 1 clinical trial evaluating abatacept in patients with steroid-refractory chronic graft-versus-host disease","volume":"131","author":"Nahas","year":"2018","journal-title":"Blood"},{"issue":"suppl 1","key":"10.1016\/j.jtct.2024.04.013_bib0017","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1182\/blood-2022-156340","article-title":"Ruxolitinib for treatment of steroid refractory sclerotic chronic graft-versus-host disease (cGVHD): results of a multicenter phase II trial","volume":"140","author":"Bhatt","year":"2022","journal-title":"Blood"},{"issue":"7","key":"10.1016\/j.jtct.2024.04.013_bib0018","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0271979","article-title":"Efficacy and safety of ruxolitinib for steroid-refractory graft-versus-host disease: systematic review and meta-analysis of randomised and non-randomised studies","volume":"17","author":"Zhang","year":"2022","journal-title":"PLoS One"},{"issue":"22","key":"10.1016\/j.jtct.2024.04.013_bib0019","doi-asserted-by":"crossref","first-page":"2278","DOI":"10.1182\/blood.2021012021","article-title":"Belumosudil for chronic graft-versus-host disease after 2 or more prior lines of therapy: the ROCKstar Study","volume":"138","author":"Cutler","year":"2021","journal-title":"Blood"},{"issue":"7","key":"10.1016\/j.jtct.2024.04.013_bib0020","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1111\/jdv.18074","article-title":"Phototherapy and topical treatments for cutaneous graft vs. host disease in haematopoietic stem cell transplantation patients: a scoping review","volume":"36","author":"Rostagno","year":"2022","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.jtct.2024.04.013_bib0021","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.838494","article-title":"Established and emerging treatments of skin GvHD","volume":"13","author":"Link-Rachner","year":"2022","journal-title":"Front Immunol"},{"issue":"6","key":"10.1016\/j.jtct.2024.04.013_bib0022","first-page":"667","article-title":"PUVA-bath photochemotherapy and isotretinoin in sclerodermatous graft-versus-host disease","volume":"18","author":"Ghoreschi","year":"2008","journal-title":"Eur J Dermatol"},{"issue":"7","key":"10.1016\/j.jtct.2024.04.013_bib0023","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1016\/j.bbmt.2015.03.024","article-title":"National Institutes of Health Consensus development project on criteria for clinical trials in chronic graft-versus-host disease: V. The 2014 Ancillary Therapy and Supportive Care Working Group Report","volume":"21","author":"Carpenter","year":"2015","journal-title":"Biol Blood Marrow Transplant"},{"issue":"2","key":"10.1016\/j.jtct.2024.04.013_bib0024","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1051\/ject\/200638174","article-title":"Platelet-rich plasma and platelet gel: a review","volume":"38","author":"Everts","year":"2006","journal-title":"J Extra Corpor Technol"},{"issue":"11","key":"10.1016\/j.jtct.2024.04.013_bib0025","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1016\/S0278-2391(97)90187-7","article-title":"Platelet gel: an autologous alternative to fibrin glue with applications in oral and maxillofacial surgery","volume":"55","author":"Whitman","year":"1997","journal-title":"J Oral Maxillofac Surg"},{"issue":"5","key":"10.1016\/j.jtct.2024.04.013_bib0026","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1111\/j.1365-3148.2006.00708.x","article-title":"Differences in platelet growth factor release and leucocyte kinetics during autologous platelet gel formation","volume":"16","author":"Everts","year":"2006","journal-title":"Transfus Med"},{"issue":"20","key":"10.1016\/j.jtct.2024.04.013_bib0027","doi-asserted-by":"crossref","first-page":"7794","DOI":"10.3390\/ijms21207794","article-title":"Platelet-rich plasma: new performance understandings and therapeutic considerations in 2020","volume":"21","author":"Everts","year":"2020","journal-title":"Int J Mol Sci"},{"issue":"1","key":"10.1016\/j.jtct.2024.04.013_bib0028","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/s12929-017-0324-1","article-title":"Treatment of chronic non-healing ulcers using autologous platelet rich plasma: a case series","volume":"24","author":"Suthar","year":"2017","journal-title":"J Biomed Sci"},{"issue":"1","key":"10.1016\/j.jtct.2024.04.013_bib0029","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1186\/s13018-023-03854-x","article-title":"Efficacy and safety of autologous platelet-rich plasma for diabetic foot ulcer healing: a systematic review and meta-analysis of randomized controlled trials","volume":"18","author":"Deng","year":"2023","journal-title":"J Orthop Surg Res"},{"issue":"4","key":"10.1016\/j.jtct.2024.04.013_bib0030","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/j.survophthal.2023.02.006","article-title":"Ocular graft-versus-host disease (oGVHD): from A to Z","volume":"68","author":"Soleimani","year":"2023","journal-title":"Surv Ophthalmol"},{"issue":"6","key":"10.1016\/j.jtct.2024.04.013_bib0031","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1016\/j.survophthal.2023.06.001","article-title":"New developments in the management of persistent corneal epithelial defects","volume":"68","author":"Thia","year":"2023","journal-title":"Surv Ophthalmol"},{"key":"10.1016\/j.jtct.2024.04.013_bib0032","doi-asserted-by":"crossref","first-page":"e1558","DOI":"10.31661\/gmj.v9i0.1558","article-title":"Fibrin scaffold incorporating platelet lysate enhance follicle survival and angiogenesis in cryopreserved preantral follicle transplantation","volume":"9","author":"Rajabzadeh","year":"2020","journal-title":"Galen Med J"},{"issue":"6","key":"10.1016\/j.jtct.2024.04.013_bib0033","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.1111\/trf.14594","article-title":"Autologous blood as a source of platelet gel for the effective and safe treatment of oral chronic graft-versus-host disease","volume":"58","author":"Bojanic","year":"2018","journal-title":"Transfusion"},{"issue":"4","key":"10.1016\/j.jtct.2024.04.013_bib0034","doi-asserted-by":"crossref","first-page":"398","DOI":"10.11138\/orl\/2017.10.4.398","article-title":"Therapeutic efficiency of platelet gel for the treatment of oral ulcers related to chronic graft versus host disease after allogeneic haematopoietic stem cell transplantation","volume":"10","author":"Picardi","year":"2017","journal-title":"Oral Implantol (Rome)"},{"issue":"2","key":"10.1016\/j.jtct.2024.04.013_bib0035","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1111\/j.1537-2995.2009.02439.x","article-title":"Platelet gel for treatment of mucocutaneous lesions related to graft-versus-host disease after allogeneic hematopoietic stem cell transplant","volume":"50","author":"Picardi","year":"2010","journal-title":"Transfusion"},{"issue":"6","key":"10.1016\/j.jtct.2024.04.013_bib0036","doi-asserted-by":"crossref","first-page":"e13897","DOI":"10.1111\/dth.13897","article-title":"Evaluation of safety and efficacy of autologous topical platelet gel vs platelet rich plasma injection in the treatment of venous leg ulcers: a randomized case control study","volume":"33","author":"Elgarhy","year":"2020","journal-title":"Dermatol Ther"},{"key":"10.1016\/j.jtct.2024.04.013_bib0037","doi-asserted-by":"crossref","first-page":"942","DOI":"10.3389\/fimmu.2020.00942","article-title":"Cord blood platelet rich plasma derivatives for clinical applications in non-transfusion","volume":"11","author":"Samarkanova","year":"2020","journal-title":"Medicine Front Immunol"},{"issue":"1","key":"10.1016\/j.jtct.2024.04.013_bib0038","first-page":"73","article-title":"Multicentre standardisation of a clinical grade procedure for the preparation of allogeneic platelet concentrates from umbilical cord blood","volume":"14","author":"Rebulla","year":"2016","journal-title":"Blood Transfus"},{"issue":"6","key":"10.1016\/j.jtct.2024.04.013_bib0039","doi-asserted-by":"crossref","first-page":"5775","DOI":"10.3390\/ijms24065775","article-title":"In vitro cell proliferation and migration properties of oral mucosal fibroblasts: a comparative study on the effects of cord blood- and peripheral blood-platelet lysate","volume":"24","author":"Azmi","year":"2023","journal-title":"Int J Mol Sci"},{"issue":"4","key":"10.1016\/j.jtct.2024.04.013_bib0040","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/j.transci.2018.06.001","article-title":"Comparison of growth factor and interleukin content of adult peripheral blood and cord blood serum eye drops for cornea and ocular surface diseases","volume":"57","author":"Buzzi","year":"2018","journal-title":"Transfus Apher Sci"},{"issue":"1","key":"10.1016\/j.jtct.2024.04.013_bib0041","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1111\/iwj.13233","article-title":"In vitro human cord blood platelet lysate characterisation with potential application in wound healing","volume":"17","author":"Losi","year":"2020","journal-title":"Int Wound J"},{"issue":"12","key":"10.1016\/j.jtct.2024.04.013_bib0042","doi-asserted-by":"crossref","first-page":"2573","DOI":"10.3727\/096368915X687471","article-title":"Extensive characterization of platelet gel releasate from cord blood in regenerative medicine","volume":"24","author":"Parazzi","year":"2015","journal-title":"Cell Transplant"},{"issue":"3","key":"10.1016\/j.jtct.2024.04.013_bib0043","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.bbmt.2014.12.001","article-title":"National Institutes of Health Consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. The 2014 Diagnosis and Staging Working Group Report","volume":"21","author":"Jagasia","year":"2015","journal-title":"Biol Blood Marrow Transplant"},{"issue":"20","key":"10.1016\/j.jtct.2024.04.013_bib0044","doi-asserted-by":"crossref","first-page":"eade7007","DOI":"10.1126\/sciadv.ade7007","article-title":"Breakthrough treatments for accelerated wound healing","volume":"9","author":"Freedman","year":"2023","journal-title":"Sci Adv"},{"issue":"3","key":"10.1016\/j.jtct.2024.04.013_bib0045","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1186\/scrt218","article-title":"Platelet-rich plasma preparation for regenerative medicine: optimization and quantification of cytokines and growth factors","volume":"4","author":"Amable","year":"2013","journal-title":"Stem Cell Res Ther"},{"issue":"6","key":"10.1016\/j.jtct.2024.04.013_bib0046","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1097\/01.moh.0000177831.70657.e8","article-title":"Platelet gels and releasates","volume":"12","author":"Borzini","year":"2005","journal-title":"Curr Opin Hematol"},{"key":"10.1016\/j.jtct.2024.04.013_bib0047","first-page":"3532","article-title":"Platelets and wound healing","volume":"13","author":"Nurden","year":"2008","journal-title":"Front Biosci"},{"issue":"3","key":"10.1016\/j.jtct.2024.04.013_bib0048","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.blre.2014.10.003","article-title":"Platelet secretion: from haemostasis to wound healing and beyond","volume":"29","author":"Golebiewska","year":"2015","journal-title":"Blood Rev"},{"key":"10.1016\/j.jtct.2024.04.013_bib0049","first-page":"e38","article-title":"Use of platelet rich plasma gel on wound healing: a systematic review and meta-analysis","volume":"11","author":"Carter","year":"2011","journal-title":"Eplasty"},{"issue":"12","key":"10.1016\/j.jtct.2024.04.013_bib0050","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.1038\/bmt.2012.64","article-title":"Autologous platelet lysate for treatment of refractory ocular GVHD","volume":"47","author":"Pezzotta","year":"2012","journal-title":"Bone Marrow Transplant"},{"issue":"2","key":"10.1016\/j.jtct.2024.04.013_bib0051","doi-asserted-by":"crossref","first-page":"431","DOI":"10.3390\/ijms21020431","article-title":"Impact of the different preparation methods to obtain autologous non-activated platelet-rich plasma (A-PRP) and activated platelet-rich plasma (AA-PRP) in plastic surgery: wound healing and hair regrowth evaluation","volume":"21","author":"Gentile","year":"2020","journal-title":"Int J Mol Sci"},{"issue":"2","key":"10.1016\/j.jtct.2024.04.013_bib0052","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.tibtech.2016.11.001","article-title":"Allogeneic platelet-rich plasma: at the dawn of an off-the-shelf therapy?","volume":"35","author":"Anitua","year":"2017","journal-title":"Trends Biotechnol"},{"issue":"7","key":"10.1016\/j.jtct.2024.04.013_bib0053","doi-asserted-by":"crossref","first-page":"549","DOI":"10.3109\/09537104.2010.514626","article-title":"Platelet gel from cord blood: a novel tool for tissue engineering","volume":"21","author":"Parazzi","year":"2010","journal-title":"Platelets"},{"issue":"suppl 1","key":"10.1016\/j.jtct.2024.04.013_bib0054","first-page":"s235","article-title":"Pleural tissue repair with cord blood platelet gel","volume":"12","author":"Rosso","year":"2014","journal-title":"Blood Transfus"},{"issue":"1","key":"10.1016\/j.jtct.2024.04.013_bib0055","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1186\/s13287-015-0166-2","article-title":"Human cord blood-derived platelet lysate enhances the therapeutic activity of adipose-derived mesenchymal stromal cells isolated from Crohn's disease patients in a mouse model of colitis","volume":"6","author":"Forte","year":"2015","journal-title":"Stem Cell Res Ther"},{"issue":"7","key":"10.1016\/j.jtct.2024.04.013_bib0056","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1007\/s00403-021-02270-7","article-title":"Efficacy and safety of plasma gel versus platelet-rich plasma in periorbital rejuvenation: a comparative split-face clinical and Antera 3D camera study","volume":"314","author":"Diab","year":"2022","journal-title":"Arch Dermatol Res"},{"issue":"1","key":"10.1016\/j.jtct.2024.04.013_bib0057","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1111\/wrr.12865","article-title":"Efficacy of allogeneic cord blood platelet gel on wounds of dystrophic epidermolysis bullosa patients after pseudosyndactyly surgery","volume":"29","author":"Torkamaniha","year":"2021","journal-title":"Wound Repair Regen"},{"issue":"3","key":"10.1016\/j.jtct.2024.04.013_bib0058","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1097\/PRS.0b013e3181cb6589","article-title":"Treatment of diabetic foot ulcers using a blood bank platelet concentrate","volume":"125","author":"Jeong","year":"2010","journal-title":"Plast Reconstr Surg"},{"issue":"3","key":"10.1016\/j.jtct.2024.04.013_bib0059","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1111\/jocd.12401","article-title":"Autologous platelet-rich plasma versus conventional therapy for the treatment of chronic venous leg ulcers: a comparative study","volume":"17","author":"Moneib","year":"2018","journal-title":"J Cosmet Dermatol"}],"container-title":["Transplantation and Cellular Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S266663672400366X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S266663672400366X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T11:17:39Z","timestamp":1751368659000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S266663672400366X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7]]},"references-count":59,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2024,7]]}},"alternative-id":["S266663672400366X"],"URL":"https:\/\/doi.org\/10.1016\/j.jtct.2024.04.013","relation":{},"ISSN":["2666-6367"],"issn-type":[{"value":"2666-6367","type":"print"}],"subject":[],"published":{"date-parts":[[2024,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The Application of Umbilical Cord Blood-derived Platelet Gel for Skin Ulcers Associated With Chronic Graft-Versus-Host Disease in Pediatrics: A Randomized Trial","name":"articletitle","label":"Article Title"},{"value":"Transplantation and Cellular Therapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jtct.2024.04.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The American Society for Transplantation and Cellular Therapy. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}